MedPath

Levocabastine

Generic Name
Levocabastine
Brand Names
Livostin
Drug Type
Small Molecule
Chemical Formula
C26H29FN2O2
CAS Number
79516-68-0
Unique Ingredient Identifier
H68BP06S81

Overview

Levocabastine is a selective second-generation H1-receptor antagonist used for allergic conjunctivitis. Levocabastine was discovered at Janssen Pharmaceutica in 1979.

Background

Levocabastine is a selective second-generation H1-receptor antagonist used for allergic conjunctivitis. Levocabastine was discovered at Janssen Pharmaceutica in 1979.

Indication

As an ophthalmic for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. Also used as a nasal spray for allergic rhinitis.

Associated Conditions

  • Allergic Conjunctivitis (AC)
  • Allergic Rhinitis (AR)

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Levocabastine Hydrochloride Nasal Spray
国药准字HJ20160305
化学药品
鼻喷雾剂
3/22/2021
Levocabastine Hydrochloride Nasal Spray
国药准字HJ20160304
化学药品
鼻喷雾剂
3/22/2021

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath